Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Typ-2-Diabetes und Adipositas Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende

Die Highlights vom Kongress des American College of Cardiology 2024

Im April diskutierten die Herz-Kreislauf-Spezialisten aus der ganzen Welt auf dem  Kongress des American College of Cardiology (ACC) u.a. neue Therapieansätze bei akutem Myokardinfarkt, koronarer Herzerkrankung, kardiogenem Schock oder Aortenklappenstenose. In unserem Kongress-Dossier haben wir für Sie Berichte über die „Late-Breaking Trials“ und andere wichtige Studien zusammengestellt. 
Erweiterte Suche
Anmelden
nach oben
Pituitary
Erschienen in: Pituitary 1/2009

01.03.2009

Radiotherapy of nonfunctioning and gonadotroph adenomas

verfasst von: Andrew A. Kanner, Benjamin W. Corn, Yona Greenman

Erschienen in: Pituitary | Ausgabe 1/2009

Einloggen, um Zugang zu erhalten

Abstract

Transsphenoidal surgery is the treatment of choice for NFPA but is seldom curative. The management of patients in whom residual tumor is detected after surgery is not clear-cut. Radiation therapy is effective in controlling tumor mass in the majority of patients, but is associated with long term complications that call for restriction of its use to patients at high risk for tumor growth. New radiation techniques may prove to be safer while retaining the effectiveness of conventional radiotherapy, however longer follow-up is necessary to confirm this assumption. For now, it appears to be safe to withhold radiation and carefully follow patients with small tumor remnants, whereas large remnants from invasive tumors should be considered for radiotherapy. Nevertheless, there are no prospective controlled studies that support this empirical approach.
Literatur
1.
Saeger W et al (2007) Pathohistological classification of pituitary tumors: 10 years of experience with the German Pituitary Tumor Registry. Eur J Endocrinol 156(2):203–216PubMedCrossRef
2.
Al-Shraim M, Asa SL (2006) The 2004 World Health Organization classification of pituitary tumors: What is new? Acta Neuropathol 111(1):1–7PubMedCrossRef
3.
Yamada S et al (2007) A study of the correlation between morphological findings and biological activities in clinically nonfunctioning pituitary adenomas. Neurosurgery 61(3):580–584; discussion 584–585PubMed
4.
Breen P et al (1998) Radiotherapy for nonfunctional pituitary adenoma: analysis of long-term tumor control. J Neurosurg 89(6):933–938PubMed
5.
Greenman Y, Melmed S (1996) Diagnosis and management of nonfunctioning pituitary tumors. Annu Rev Med 47:95–106PubMedCrossRef
6.
Mastronardi L, Guiducci A (2002) Are nonfunctioning pituitary adenomas extending into the cavernous sinus aggressive and/or invasive? Neurosurgery 51(2):521–522; author reply 522PubMedCrossRef
7.
Vance ML (1997) Nonfunctioning pituitary adenoma. Curr Ther Endocrinol Metab 6:33–35PubMed
8.
Ciric I et al (1983) Transsphenoidal microsurgery of pituitary macroadenomas with long-term follow-up results. J Neurosurg 59(3):395–401PubMed
9.
Black PM, Zervas NT, Candia G (1988) Management of large pituitary adenomas by transsphenoidal surgery. Surg Neurol 29(6):443–447PubMedCrossRef
10.
Ferrante E et al (2006) Non-functioning pituitary adenoma database: a useful resource to improve the clinical management of pituitary tumors. Eur J Endocrinol 155(6):823–829PubMedCrossRef
11.
Honegger J et al (2007) Objective criteria for successful transsphenoidal removal of suprasellar nonfunctioning pituitary adenomas. A prospective study. Acta Neurochir (Wien) 149(1):21–29; discussion 29CrossRef
12.
Zhang X et al (1999) Management of nonfunctioning pituitary adenomas with suprasellar extensions by transsphenoidal microsurgery. Surg Neurol 52(4):380–385PubMedCrossRef
13.
Kanner AA et al (2002) Intracranial navigation by using low-field intraoperative magnetic resonance imaging: preliminary experience. J Neurosurg 97(5):1115–1124PubMed
14.
Brada M et al (1993) The long-term efficacy of conservative surgery and radiotherapy in the control of pituitary adenomas. Clin Endocrinol (Oxf) 38(6):571–578CrossRef
15.
Bradley KM et al (1994) An audit of selected patients with non-functioning pituitary adenoma treated by transsphenoidal surgery without irradiation. Clin Endocrinol (Oxf) 41(5):655–659CrossRef
16.
Comtois R et al (1991) The clinical and endocrine outcome to trans-sphenoidal microsurgery of nonsecreting pituitary adenomas. Cancer 68(4):860–866PubMedCrossRef
17.
Ebersold MJ et al (1986) Long-term results in transsphenoidal removal of nonfunctioning pituitary adenomas. J Neurosurg 64(5):713–719PubMed
18.
Arita K et al (2006) Natural course of incidentally found nonfunctioning pituitary adenoma, with special reference to pituitary apoplexy during follow-up examination. J Neurosurg 104(6):884–891PubMedCrossRef
19.
Dekkers OM et al (2007) The natural course of non-functioning pituitary macroadenomas. Eur J Endocrinol 156(2):217–224PubMedCrossRef
20.
Karavitaki N et al (2007) What is the natural history of nonoperated nonfunctioning pituitary adenomas? Clin Endocrinol (Oxf) 67(6):938–943CrossRef
21.
Gittoes NJ (2003) Radiotherapy for non-functioning pituitary tumors–when and under what circumstances? Pituitary 6(2):103–108PubMedCrossRef
22.
Dekkers OM et al (2006) Observation alone after transsphenoidal surgery for nonfunctioning pituitary macroadenoma. J Clin Endocrinol Metab 91(5):1796–1801PubMedCrossRef
23.
Park P et al (2004) The role of radiation therapy after surgical resection of nonfunctional pituitary macroadenomas. Neurosurgery 55(1):100–106; discussion 106–107PubMedCrossRef
24.
Turner HE et al (1999) Audit of selected patients with nonfunctioning pituitary adenomas treated without irradiation - a follow-up study. Clin Endocrinol (Oxf) 51(3):281–284CrossRef
25.
Buch HN et al (2004) Prediction of recurrence of nonfunctioning pituitary tumours by loss of heterozygosity analysis. Clin Endocrinol (Oxf) 61(1):19–25CrossRef
26.
Dubois S et al (2007) Relevance of Ki-67 and prognostic factors for recurrence/progression of gonadotropic adenomas after first surgery. Eur J Endocrinol 157(2):141–147PubMedCrossRef
27.
Kontogeorgos G (2006) Predictive markers of pituitary adenoma behavior. Neuroendocrinology 83(3–4):179–188PubMedCrossRef
28.
Tanaka Y et al (2003) Growth pattern and rate in residual nonfunctioning pituitary adenomas: correlations among tumor volume doubling time, patient age, and MIB-1 index. J Neurosurg 98(2):359–365PubMed
29.
Lillehei KO et al (1998) Reassessment of the role of radiation therapy in the treatment of endocrine-inactive pituitary macroadenomas. Neurosurgery 43(3):432–438; discussion 438–439PubMedCrossRef
30.
Greenman Y et al (2003) Postoperative surveillance of clinically nonfunctioning pituitary macroadenomas: markers of tumour quiescence and regrowth. Clin Endocrinol (Oxf) 58(6):763–769CrossRef
31.
Greenman Y (2007) Dopaminergic treatment of nonfunctioning pituitary adenomas. Nat Clin Pract Endocrinol Metab 3(8):554–555PubMedCrossRef
32.
Greenman Y et al (2005) Postoperative treatment of clinically nonfunctioning pituitary adenomas with dopamine agonists decreases tumour remnant growth. Clin Endocrinol (Oxf) 63(1):39–44CrossRef
33.
Greenman Y et al (1998) The use of beta-subunits of gonadotrophin hormones in the follow-up of clinically non-functioning pituitary tumours. Clin Endocrinol (Oxf) 49(2):185–190CrossRef
34.
Kremer P et al (2002) Magnetic resonance imaging after transsphenoidal surgery of clinically non-functional pituitary macroadenomas and its impact on detecting residual adenoma. Acta Neurochir (Wien) 144(5):433–443CrossRef
35.
Wowra B, Stummer W (2002) Efficacy of gamma knife radiosurgery for nonfunctioning pituitary adenomas: a quantitative follow up with magnetic resonance imaging-based volumetric analysis. J Neurosurg 97(5 Suppl):429–432PubMed
36.
Gittoes NJ et al (1998) Radiotherapy for non-function pituitary tumours. Clin Endocrinol (Oxf) 48(3):331–337CrossRef
37.
Jaffrain-Rea ML et al (1993) Influence of radiotherapy on long-term relapse in clinically non-secreting pituitary adenomas. A retrospective study (1970–1988). Eur J Med 2(7):398–403PubMed
38.
Tsang RW et al (1994) Radiation therapy for pituitary adenoma: treatment outcome and prognostic factors. Int J Radiat Oncol Biol Phys 30(3):557–565PubMed
39.
Woollons AC et al (2000) Non-functioning pituitary adenomas: indications for postoperative radiotherapy. Clin Endocrinol (Oxf) 53(6):713–717CrossRef
40.
van den Bergh AC et al (2007) Immediate postoperative radiotherapy in residual nonfunctioning pituitary adenoma: beneficial effect on local control without additional negative impact on pituitary function and life expectancy. Int J Radiat Oncol Biol Phys 67(3):863–869PubMed
41.
Tomlinson JW et al (2001) Association between premature mortality and hypopituitarism. West Midlands Prospective Hypopituitary Study Group. Lancet 357(9254):425–431PubMedCrossRef
42.
Mayberg M, Vermeulen S (2007) Advances in stereotactic radiosurgery in the treatment of pituitary adenomas. Curr Opin Endocrinol Diabetes Obes 14(4):296–300PubMed
43.
Yoon SC et al (1998) Clinical results of 24 pituitary macroadenomas with linac-based stereotactic radiosurgery. Int J Radiat Oncol Biol Phys 41(4):849–853PubMed
44.
Muramatsu J et al (2003) [Clinical results of LINAC-based stereotactic radiosurgery for pituitary adenoma]. Nippon Igaku Hoshasen Gakkai Zasshi 63(5):225–230PubMed
45.
Leber KA, Bergloff J, Pendl G (1998) Dose-response tolerance of the visual pathways and cranial nerves of the cavernous sinus to stereotactic radiosurgery. J Neurosurg 88(1):43–50PubMed
46.
Feigl GC et al (2002) Effects of gamma knife radiosurgery of pituitary adenomas on pituitary function. J Neurosurg 97(5 Suppl):415–421PubMed
47.
Lim YL et al (1998) Four years’ experiences in the treatment of pituitary adenomas with gamma knife radiosurgery. Stereotact Funct Neurosurg 70(Suppl 1):95–109PubMedCrossRef
48.
Liscak R et al (2007) Gamma knife radiosurgery for endocrine-inactive pituitary adenomas. Acta Neurochir (Wien) 149(10):999–1006CrossRef
49.
Muacevic A, Uhl E, Wowra B (2004) Gamma knife radiosurgery for nonfunctioning pituitary adenomas. Acta Neurochir Suppl 91:51–54PubMed
50.
Petrovich Z et al (2003) Gamma knife radiosurgery for pituitary adenoma: early results. Neurosurgery 53(1):51–59; discussion 59–61PubMedCrossRef
51.
Izawa M et al (2000) Gamma knife radiosurgery for pituitary adenomas. J Neurosurg 93(Suppl 3):19–22PubMed
52.
Ikeda H, Jokura H, Yoshimoto T (1998) Gamma knife radiosurgery for pituitary adenomas: usefulness of combined transsphenoidal and gamma knife radiosurgery for adenomas invading the cavernous sinus. Radiat Oncol Investig 6(1):26–34PubMedCrossRef
53.
Losa M et al (2004) Gamma knife surgery for treatment of residual nonfunctioning pituitary adenomas after surgical debulking. J Neurosurg 100(3):438–444PubMed
54.
Mingione V et al (2006) Gamma surgery in the treatment of nonsecretory pituitary macroadenoma. J Neurosurg 104(6):876–883PubMedCrossRef
55.
Mitsumori M et al (1998) Initial clinical results of LINAC-based stereotactic radiosurgery and stereotactic radiotherapy for pituitary adenomas. Int J Radiat Oncol Biol Phys 42(3):573–580PubMed
56.
Voges J et al (2006) Linear accelerator radiosurgery for pituitary macroadenomas: a 7-year follow-up study. Cancer 107(6):1355–1364PubMedCrossRef
57.
Pamir MN et al (2007) Pituitary adenomas treated with gamma knife radiosurgery: volumetric analysis of 100 cases with minimum 3 year follow-up. Neurosurgery 61(2):270–280; discussion 280PubMedCrossRef
58.
Pan L et al (1998) Pituitary adenomas: the effect of gamma knife radiosurgery on tumor growth and endocrinopathies. Stereotact Funct Neurosurg 70(Suppl 1):119–126PubMedCrossRef
59.
Picozzi P et al (2005) Radiosurgery and the prevention of regrowth of incompletely removed nonfunctioning pituitary adenomas. J Neurosurg 102(Suppl):71–74PubMedCrossRef
60.
Sheehan JP et al (2003) Radiosurgery for nonfunctioning pituitary adenoma. Neurosurg Focus 14(5):e9PubMedCrossRef
61.
Iwai Y, Yamanaka K, Yoshioka K (2005) Radiosurgery for nonfunctioning pituitary adenomas. Neurosurgery 56(4):699–705; discussion 699–705PubMedCrossRef
62.
63.
Sheehan JP et al (2002) Radiosurgery for residual or recurrent nonfunctioning pituitary adenoma. J Neurosurg 97(5 Suppl):408–414PubMed
64.
Mokry M et al (1999) A six year experience with the postoperative radiosurgical management of pituitary adenomas. Stereotact Funct Neurosurg 72(Suppl 1):88–100PubMedCrossRef
65.
Pollock BE, Carpenter PC (2003) Stereotactic radiosurgery as an alternative to fractionated radiotherapy for patients with recurrent or residual nonfunctioning pituitary adenomas. Neurosurgery 53(5):1086–1091; discussion 1091–1094PubMedCrossRef
66.
Shin M et al (2000) Stereotactic radiosurgery for pituitary adenoma invading the cavernous sinus. J Neurosurg 93(Suppl 3):2–5PubMed
67.
Laws ER et al (2004) Stereotactic radiosurgery for pituitary adenomas: a review of the literature. J Neurooncol 69(1–3):257–272PubMedCrossRef
68.
Sheehan JP et al (2006) Stereotactic radiosurgery for pituitary adenomas: a review of the literature and our experience. Front Horm Res 34:185–205PubMedCrossRef
69.
Sheehan JP et al (2005) Stereotactic radiosurgery for pituitary adenomas: an intermediate review of its safety, efficacy, and role in the neurosurgical treatment armamentarium. J Neurosurg 102(4):678–691PubMed
70.
71.
Plowman PN, Doughty D (1999) Stereotactic radiosurgery, X: clinical isodosimetry of gamma knife versus linear accelerator X-knife for pituitary and acoustic tumours. Clin Oncol (R Coll Radiol) 11(5):321–329
72.
Rocher FP et al (1995) Stereotactic radiosurgery: the Lyon experience. Acta Neurochir Suppl 63:109–114PubMed
73.
Martinez R et al (1998) Pituitary tumors and gamma knife surgery. Clinical experience with more than two years of follow-up. Stereotact Funct Neurosurg 70(Suppl 1):110–118PubMedCrossRef
74.
Inoue HK et al (1999) Pituitary adenomas treated by microsurgery with or without Gamma Knife surgery: experience in 122 cases. Stereotact Funct Neurosurg 72(Suppl 1):125–131PubMedCrossRef
75.
Hall EJ (2000) Radiobiology for the radiologist, 5th edn. Lippincott Williams & Wilkins, Philadelphia
76.
Milker-Zabel S et al (2001) Fractionated stereotactically guided radiotherapy and radiosurgery in the treatment of functional and nonfunctional adenomas of the pituitary gland. Int J Radiat Oncol Biol Phys 50(5):1279–1286PubMed
77.
Colin P et al (2005) Treatment of pituitary adenomas by fractionated stereotactic radiotherapy: a prospective study of 110 patients. Int J Radiat Oncol Biol Phys 62(2):333–341PubMed
78.
Paek SH et al (2005) Integration of surgery with fractionated stereotactic radiotherapy for treatment of nonfunctioning pituitary macroadenomas. Int J Radiat Oncol Biol Phys 61(3):795–808PubMed
79.
Minniti G et al (2006) Fractionated stereotactic conformal radiotherapy for secreting and nonsecreting pituitary adenomas. Clin Endocrinol (Oxf) 64(5):542–548CrossRef
80.
McClelland S 3rd et al (2007) Fractionated stereotactic radiotherapy for pituitary adenomas following microsurgical resection: safety and efficacy. Technol Cancer Res Treat 6(3):177–180PubMed
81.
Mackley HB et al (2007) Intensity-modulated radiotherapy for pituitary adenomas: the preliminary report of the Cleveland Clinic experience. Int J Radiat Oncol Biol Phys 67(1):232–239PubMed
Metadaten
Titel
Radiotherapy of nonfunctioning and gonadotroph adenomas
verfasst von
Andrew A. Kanner
Benjamin W. Corn
Yona Greenman
Publikationsdatum
01.03.2009
Verlag
Springer US
Erschienen in
Pituitary / Ausgabe 1/2009
Print ISSN: 1386-341X
Elektronische ISSN: 1573-7403
DOI
https://doi.org/10.1007/s11102-008-0089-3

Weitere Artikel der Ausgabe 1/2009

Pituitary 1/2009 Zur Ausgabe

Case Report

Primary central nervous system lymphoma mimicking pituitary apoplexy: case report

OriginalPaper

Cushing’s disease: radiation therapy

Case Report

A primary sellar esthesioneuroblastomas with unusual presentations: a case report and reviews of literatures

OriginalPaper

Radiotherapy of other sellar lesions

Guest Editorial

Pituitary radiotherapy

OriginalPaper

Radiotherapy and radiosurgery in acromegaly

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Chronische Verstopfung: „Versuchen Sie es mit grünen Kiwis!“

22.05.2024 Obstipation Nachrichten

Bei chronischer Verstopfung wirken Kiwis offenbar besser als Flohsamenschalen. Das zeigen die Daten aus einer randomisierten Studie, die der Gastroenterologe Oliver Pech beim Praxis-Update vorstellte.

Blutdrucksenkung könnte Uterusmyome verhindern

21.05.2024 Krebsvorsorge in der Gynäkologie Nachrichten

Frauen mit unbehandelter oder neu auftretender Hypertonie haben ein deutlich erhöhtes Risiko für Uterusmyome. Eine Therapie mit Antihypertensiva geht hingegen mit einer verringerten Inzidenz der gutartigen Tumoren einher.

„Jeder Fall von plötzlichem Tod muss obduziert werden!“

17.05.2024 Plötzlicher Herztod Nachrichten

Ein signifikanter Anteil der Fälle von plötzlichem Herztod ist genetisch bedingt. Um ihre Verwandten vor diesem Schicksal zu bewahren, sollten jüngere Personen, die plötzlich unerwartet versterben, ausnahmslos einer Autopsie unterzogen werden.

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise